Tolcapone

In the US, Tolcapone (tolcapone systemic) is a member of the drug class dopaminergic antiparkinsonism agents and is used to treat Parkinson's Disease.

US matches:

• Tolcapone

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N04BX01

CAS registry number (Chemical Abstracts Service)

0134308-13-7

Chemical Formula

C14-H11-N-O5

Molecular Weight

273

Therapeutic Categories

Treatment of Parkinson's disease

COMT inhibitor

Chemical Names

3,4-Dihydroxy-4'-methyl-5-nitrobenzophenon (IUPAC)

Methanone, (3,4-dihydroxy-5-nitrophenyl)(4-methyl-phenyl)-

Foreign Names

• Tolcaponum (Latin)
• Tolcapon (German)
• Tolcapone (French)
• Tolcapona (Spanish)

Generic Names

• Tolcapone (OS: USAN, BAN)
• Ro 40-7592 (IS: Roche)
• Tolcapone (PH: USP 32)

Brand Names

• Tasmar
  Meda, Belgium; Meda, Switzerland; Meda, Ireland; Meda, Luxembourg; Meda, Sweden; Pacific, New Zealand; Pharmaco, South Africa; Roche, Brazil; Roche, Chile; Valeant, Argentina; Valeant, Austria; Valeant, Costa Rica; Valeant, Czech Republic; Valeant, Germany; Valeant, Denmark; Valeant, Spain; Valeant, Finland; Valeant, France; Valeant, United Kingdom; Valeant, Italy; Valeant, Mexico; Valeant, Netherlands; Valeant, Peru; Valeant, Philippines; Valeant, Russian Federation; Valeant, Singapore; Valeant, Slovakia; Valeant, United States; Valeant Pharmaceuticals, Slovenia

International Drug Name Search

Glossary

BAN	British Approved Name
IUPAC	International Union of Pure and Applied Chemistry
IS	Inofficial Synonym
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.